• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION PROMUS PREMIER; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION PROMUS PREMIER; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Model Number 9550
Device Problems Fracture (1260); Material Deformation (2976)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 02/19/2019
Event Type  Injury  
Manufacturer Narrative
Device is a combination product.
 
Event Description
It was reported that stent fracture occurred.The 60% stenosed, 14mmx3.5mm target lesion was located in the mildly tortuous and mildly calcified left anterior descending artery.Following pre-dilatation with a balloon catheter, a 20 x 3.50 promus premier drug-eluting stent was advanced for treatment.However, upon removal, it was noted that some parts of the stent were missing.The patient was noted to be under observation.No patient complications were reported and the patient's status was noted to be stable.
 
Manufacturer Narrative
Device is a combination product.Describe event or problem updated.
 
Event Description
It was reported that stent fracture occurred.The 60% stenosed, 14mmx3.5mm target lesion was located in the mildly tortuous and mildly calcified left anterior descending artery.Following pre-dilatation with a balloon catheter, a 20 x 3.50 promus premier drug-eluting stent was advanced for treatment.However, upon removal, it was noted that some parts of the stent were missing.The patient was noted to be under observation.No patient complications were reported and the patient's status was noted to be stable.It was further reported that after the stent was implanted, intravascular ultrasound was performed and the stent was found to have a gap/breach.
 
Manufacturer Narrative
Device is a combination product.Device evaluated by mfr.: device was not returned for analysis.However, a media was received and reviewed.The review concluded that there was no evidence of any stent structural damage or missing stent material.The images provided identified signs of stent mal-apposition, the images were found to be consistent with a gap between the stent and vessel wall.
 
Event Description
It was reported that stent fracture occurred.The 60% stenosed, 14mmx3.5mm target lesion was located in the mildly tortuous and mildly calcified left anterior descending (lad) artery.Following pre-dilatation with a balloon catheter, a 20 x 3.50 promus premier drug-eluting stent was advanced for treatment.However, upon removal, it was noted that some parts of the stent were missing.The patient was noted to be under observation.No patient complications were reported and the patient's status was noted to be stable.It was further reported that after the stent was implanted, intravascular ultrasound was performed and the stent was found to have a gap/breach.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROMUS PREMIER
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
MDR Report Key8404897
MDR Text Key138271342
Report Number2134265-2019-01931
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Type of Report Initial,Followup,Followup
Report Date 05/09/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/22/2020
Device Model Number9550
Device Catalogue Number9550
Device Lot Number0021679168
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/28/2019
Initial Date Manufacturer Received 02/19/2019
Initial Date FDA Received03/08/2019
Supplement Dates Manufacturer Received03/13/2019
04/18/2019
Supplement Dates FDA Received03/28/2019
05/09/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age54 YR
Patient Weight78
-
-